Header Logo

Connection

JENNIFER FOSTER to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications JENNIFER FOSTER has written about Drug Resistance, Neoplasm.
JENNIFER FOSTER
Connection Strength
0.171
Drug Resistance, Neoplasm
  1. Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615). Eur J Cancer. 2024 Sep; 209:114241.
    View in: PubMed
    Score: 0.171
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.